Biosimilar filgrastim (Zarzio(®)) vs. lenograstim (Myelostim(®)) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience.

The combination of chemotherapy and granulocyte-colony stimulating factor (G-CSF) in patients with hematologic malignancies is considered the best regimen to mobilize peripheral blood hematopoietic...